New approaches in the management of chronic hepatitis B: role of tenofovir.
Journal Information
Full Title: Infect Drug Resist
Abbreviation: Infect Drug Resist
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures: Prof. HLA Janssen has received grants from, and is consultant for, Bristol-Myers Squibb, Gilead, Novartis, Roche and Schering-Plough. JGP Reijnders has no disclosures."
"Disclosures: Prof. HLA Janssen has received grants from, and is consultant for, Bristol-Myers Squibb, Gilead, Novartis, Roche and Schering-Plough. JGP Reijnders has no disclosures."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025